A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality.

Abstract:

OBJECTIVE:The objective of this research is to identify and determine the relative importance of dietary and environmental risk and risk reduction factors for prostate cancer mortality. MATERIALS AND METHODS:A multicountry ecologic approach was used in multivariate regression analyses with prostate cancer mortality rates and dietary factors and solar ultraviolet-B (UV-B) radiation. Prostate cancer mortality rates for 32 predominantly Caucasian countries for the late 1990s were obtained from the World Health Organization. Dietary supply data were obtained from the Food and Agriculture Organization. Annual solar UV-B dose data were obtained from European ground stations and used to estimate values elsewhere. Linear and multiple linear regression analyses were conducted for all 32 countries as well as the 20 European countries. RESULTS:The strongest risk factor for prostate cancer mortality was animal products, with the nonfat portion of milk and alcohol being somewhat weaker; the strongest risk reduction factors were onions, other protective vegetable products (excluding alcohol, oils, and sweeteners), and solar UV-B radiation. Dietary data for 1979-81 yielded the highest correlations. CONCLUSIONS:These results are consistent with insulin-like growth factor-I (IGF-I), being an important risk factor for prostate cancer, with alcohol and calcium being less important risk factors, and with allium family vegetables, and, to a lesser extent, vitamin D being important risk reduction factors. These results should provide guidance for additional studies on dietary and environmental links to prostate cancer.

journal_name

Eur Urol

journal_title

European urology

authors

Grant WB

doi

10.1016/j.eururo.2003.08.018

keywords:

subject

Has Abstract

pub_date

2004-03-01 00:00:00

pages

271-9

issue

3

eissn

0302-2838

issn

1873-7560

pii

S0302283803005359

journal_volume

45

pub_type

杂志文章,多中心研究
  • Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer.

    abstract::The present study was designed to evaluate the role of the cytokeratin-19 fragment (CYFRA 21-1) as a tumor marker in bladder cancer. The bladder cancer cell line JMSU1 was used in the preclinical study. Subjects comprised 120 healthy volunteers, 20 patients with benign bladder diseases including acute cystitis and bla...

    journal_title:European urology

    pub_type: 杂志文章

    doi:

    authors: Morita T,Kikuchi T,Hashimoto S,Kobayashi Y,Tokue A

    更新日期:1997-01-01 00:00:00

  • Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

    abstract:OBJECTIVE:To define the optimum tamoxifen dose for reducing bicalutamide (CASODEX) 150 mg monotherapy-induced breast events (ie, gynaecomastia or breast pain or both) without compromising disease control. METHODS:This was a double-blind, parallel-group, multicentre trial in which 282 patients with prostate cancer were...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.eururo.2007.01.031

    authors: Fradet Y,Egerdie B,Andersen M,Tammela TL,Nachabe M,Armstrong J,Morris T,Navani S

    更新日期:2007-07-01 00:00:00

  • Acute pancreatitis following transurethral resection of prostate.

    abstract::Three cases of acute pancreatitis following transurethral resection of the prostate are reported. The incidence is rare. A review of perioperative data failed to disclose any unique factor except in 1 patient who had an underlying biliary tract disease. Hyperamylasemia or hyperlipaemia in association with abdominal pa...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474643

    authors: Lee MH,Chen KK,Lin AT,Lee YH,Chen MT,Chang LS

    更新日期:1993-01-01 00:00:00

  • Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer.

    abstract::Active surveillance (AS) has emerged as the preferred management strategy for many men with prostate cancer (PC); however, insufficient longitudinal monitoring may increase the risk of poor outcomes. We sought to determine rates of patients becoming lost to follow-up (LTFU) and associated risk factors in a large AS co...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2018.08.010

    authors: Ginsburg KB,Auffenberg GB,Qi J,Powell IJ,Linsell SM,Montie JE,Miller DC,Cher ML

    更新日期:2018-12-01 00:00:00

  • Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.

    abstract:OBJECTIVE:Treatment of patients with mucosal prostatic urethral transitional cell carcinoma (TCC) is controversial. In this study, we evaluated the outcome of patients with mucosal prostatic urethral TCC who were managed conservatively. METHODS:The data of 290 consecutive male patients with superficial TCC of the blad...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2003.12.014

    authors: Canda AE,Tuzel E,Mungan MU,Yorukoglu K,Kirkali Z

    更新日期:2004-04-01 00:00:00

  • Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?

    abstract::In previous reports, neuron-specific enolase (NSE) has been considered to be a useful tumor marker in renal cell carcinoma (RCC). This led us to perform a prospective clinical trial in this field. NSE was checked as a tumor marker for diagnosis and monitoring of patients with RCC. We report on 55 patients and their NS...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474336

    authors: Gross AJ,Michl UH,Bornhöft G,Dieckmann KP

    更新日期:1993-01-01 00:00:00

  • Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer?

    abstract:BACKGROUND:Despite evidence that shows no survival advantage, many older patients receive primary androgen-deprivation therapy (PADT) shortly after the diagnosis of localized prostate cancer (PCa). OBJECTIVE:This study evaluates whether the early use of PADT affects the subsequent receipt of additional palliative canc...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2012.05.003

    authors: Lu-Yao GL,Albertsen PC,Li H,Moore DF,Shih W,Lin Y,DiPaola RS,Yao SL

    更新日期:2012-12-01 00:00:00

  • Ultrastructural changes of bladder cancer cells following methylene blue-sensitized photodynamic treatment.

    abstract::The cytotoxic efficacy of methylene blue-sensitized photoinactivation of bladder cancer cells has been proved in vitro and in vivo in our previous work. The ultrastructural changes of MBT-2 murine bladder cancer cells following methylene blue-sensitized phototherapy have been evaluated by scanning and transmission ele...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473652

    authors: Yu DS,Chang SY,Ma CP

    更新日期:1991-01-01 00:00:00

  • Needle tract seeding following puncture of retroperitoneal liposarcoma.

    abstract::9 case of needle tract seeding following percutaneous puncture of an avascular mass, which proved to be a retroperitoneal liposarcoma, is presented. ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474128

    authors: Hidai H,Sakuramoto T,Miura T,Nakahashi M,Kikyo S

    更新日期:1983-01-01 00:00:00

  • Differential diagnosis of testicular mass by cytological examination of seminal fluid collected by ejaculation or prostatic massage.

    abstract::The cytological examination of the seminal fluid of 3 patients with painless testicular masses was performed using an ordinary conventional technique. Neoplastic cells appeared in the ejaculate or fluid from prostatic massage of all patients. The final pathologies were seminoma, choriocarcinoma and mixed teratocarcino...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000463907

    authors: Yu DS,Wang J,Chang SY,Ma CP

    更新日期:1990-01-01 00:00:00

  • 48- to 96-hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution.

    abstract::In 1976 a standardised hypertonic 'intracellular' perfusate (Euro-Collins solution) was recommended for renal preservation in all donor centres collaborating with the Eurotransplant Organisation. In order to investigate the effectiveness of this perfusate canine kidneys were initially flushed with Euro-Collins solutio...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473336

    authors: Dreikorn K,Horsch R,Röhl L

    更新日期:1980-01-01 00:00:00

  • Tumor collagenase-stimulating factor and tumor autocrine motility factor as tumor markers in bladder cancer--an update.

    abstract::We have studied the role of combined measurements of tumor collagenase-stimulating factor (TCSF) and tumor autocrine motility factor (TAMF) in 83 first morning voids and 24-hour specimens in patients with bladder and renal cancer and control subjects. TCSF and TAMF were measured by immunoabsorption assay and motility ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474877

    authors: Javadpour N,Guirguis R

    更新日期:1992-01-01 00:00:00

  • Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.

    abstract:OBJECTIVE:evaluation of a self-injection program with a mixture of papaverine, phentolamine and prostaglandin E1 (PGE1). METHOD:a self-injection program for erectile dysfunction was started by 48 patients, using a 1-ml mixture of 4.5 mg papaverine, 0.2 mg phentolamine and 1.5 micrograms PGE1. Patients completed a ques...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000475407

    authors: Meinhardt W,Lycklama à Nijeholt AA,Kropman RF,Vermeij P,Zwartendijk J

    更新日期:1994-01-01 00:00:00

  • Incidence and remission of female urinary incontinence over 6.5 years: analysis of a health screening project.

    abstract:OBJECTIVES:To analyse the incidence and remission of female urinary incontinence (UI) over 6.5 years and to identify risk factors for the development of UI. METHODS:Women who underwent a health investigation in 1998 or 1999 in the area of Vienna completed the Bristol Female Lower Urinary Tract Symptoms questionnaire. ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2006.02.010

    authors: Wehrberger C,Temml C,Ponholzer A,Madersbacher S

    更新日期:2006-08-01 00:00:00

  • Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

    abstract:BACKGROUND:Patients with end-stage renal disease (ESRD) are at risk of developing renal tumours. OBJECTIVE:Compare clinical, pathologic, and outcome features of renal cell carcinomas (RCCs) in ESRD patients and in patients from the general population. DESIGN, SETTING, AND PARTICIPANTS:Twenty-four French university de...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.eururo.2011.02.035

    authors: Neuzillet Y,Tillou X,Mathieu R,Long JA,Gigante M,Paparel P,Poissonnier L,Baumert H,Escudier B,Lang H,Rioux-Leclercq N,Bigot P,Bernhard JC,Albiges L,Bastien L,Petit J,Saint F,Bruyere F,Boutin JM,Brichart N,Karam G

    更新日期:2011-08-01 00:00:00

  • Transurethral prostatectomy: a long-term follow-up study of 166 patients over 80 years of age.

    abstract:OBJECTIVES AND METHODS:In a retrospective analysis, the medical records of 166 patients over 80 years of age (80-99 years, mean age 82 years) who underwent transurethral prostatectomy (TURP) for clinically benign prostatic hyperplasia (BPH) were reviewed in order to evaluate the morbidity and mortality rates in this sp...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474208

    authors: Matani Y,Mottrie AM,Stöckle M,Voges GE,Fichtner J,Hohenfellner R

    更新日期:1996-01-01 00:00:00

  • Genomic Predictors of Outcome in Prostate Cancer.

    abstract:CONTEXT:Given the highly variable behavior and clinical course of prostate cancer (PCa) and the multiple available treatment options, a personalized approach to oncologic risk stratification is important. Novel genetic approaches offer additional information to improve clinical decision making. OBJECTIVE:To review the...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2015.04.008

    authors: Boström PJ,Bjartell AS,Catto JW,Eggener SE,Lilja H,Loeb S,Schalken J,Schlomm T,Cooperberg MR

    更新日期:2015-12-01 00:00:00

  • Mucosal morphology of ileal conduits with particular reference to urinary infections.

    abstract::Mucosal biopsies were obtained for histological and electron microscopical studies from 20 patients with ileal urinary conduits. Special interest was focused on problems of urinary tract infections and their possible role in the pathogenesis of these changes. Chronic inflammation with mild to total villous atrophy was...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000472616

    authors: Lindell O,Mäkinen J,Nickels J,Lehtonen T

    更新日期:1986-01-01 00:00:00

  • Laparoscopic surgery versus antegrade scrotal sclerotherapy: Retrospective comparison of two different approaches for varicocele treatment.

    abstract:OBJECTIVE:Both laparoscopic surgery and antegrade sclerotherapy are effective treatment options in the management of varicoceles. However, very limited data comparing these two approaches are available in the literature. We present our experience regarding outcome and complications with each treatment modality. PATIEN...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2005.10.023

    authors: May M,Johannsen M,Beutner S,Helke C,Braun KP,Lein M,Roigas J,Hoschke B

    更新日期:2006-02-01 00:00:00

  • Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.

    abstract:OBJECTIVES:To evaluate the efficacy, tolerability, endocrinological effects and the pharmacokinetics of Casodex, when given as monotherapy during daily dosing of 10-200 mg to patients with advanced prostate cancer. METHODS:A total of 390 patients with advanced prostate cancer were treated for a minimum of 12 weeks wit...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000019526

    authors: Tyrrell CJ,Denis L,Newling D,Soloway M,Channer K,Cockshott ID

    更新日期:1998-01-01 00:00:00

  • Methotrexate, vinblastine, adriamycin and cisplatin versus methotrexate and cisplatin in advanced urothelial cancer. A randomized study.

    abstract::From September 1984 to December 1988, 28 consecutive patients with metastatic urothelial cancer entered a randomized study to compare 4 courses of modified methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) to 4 courses of methotrexate followed by folinic acid rescue and cisplatin (MP). Non-responders or rela...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000471672

    authors: Pizzocaro G,Milani A,Piva L,Faustini M,Spino E

    更新日期:1991-01-01 00:00:00

  • Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.

    abstract:BACKGROUND:Relatively little is known about the relationship between race/ethnicity and patient-reported outcomes after contemporary treatments for localized prostate cancer. OBJECTIVE:To test the hypothesis that treatment-related changes in urinary, bowel, sexual, and hormonal function vary by race/ethnicity. DESIGN...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.eururo.2016.10.036

    authors: Tyson MD,Alvarez J,Koyama T,Hoffman KE,Resnick MJ,Wu XC,Cooperberg MR,Goodman M,Greenfield S,Hamilton AS,Hashibe M,Paddock LE,Stroup A,Chen VW,Penson DF,Barocas DA

    更新日期:2017-08-01 00:00:00

  • The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.

    abstract:CONTEXT:Biomarker-driven cancer therapy, also referred to as precision oncology, has received increasing attention for its promise of improving patient outcomes by defining subsets of patients more likely to respond to various therapies. OBJECTIVE:In this collaborative review article, we examine recent literature rega...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2016.08.024

    authors: Barbieri CE,Chinnaiyan AM,Lerner SP,Swanton C,Rubin MA

    更新日期:2017-02-01 00:00:00

  • Vesicoureteral reflux: current trends in diagnosis, screening, and treatment.

    abstract:CONTEXT:Vesicoureteral reflux (VUR) is present in approximately 1% of children in North America and Europe and is associated with an increased risk of pyelonephritis and renal scarring. Despite its prevalence and potential morbidity, however, many aspects of VUR management are controversial. OBJECTIVE:Review the evide...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2012.01.002

    authors: Routh JC,Bogaert GA,Kaefer M,Manzoni G,Park JM,Retik AB,Rushton HG,Snodgrass WT,Wilcox DT

    更新日期:2012-04-01 00:00:00

  • Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up.

    abstract:OBJECTIVE:Prospectively evaluate perioperative outcomes and 2-yr follow-up after holmium laser enucleation (HoLEP) and standard open prostatectomy (OP) for treating benign prostatic hyperplasia-related obstructed voiding symptoms, with prostates >70 g. METHODS:From March 2003 to December 2004, 80 consecutive patients ...

    journal_title:European urology

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.eururo.2006.04.003

    authors: Naspro R,Suardi N,Salonia A,Scattoni V,Guazzoni G,Colombo R,Cestari A,Briganti A,Mazzoccoli B,Rigatti P,Montorsi F

    更新日期:2006-09-01 00:00:00

  • Improving bladder neck division in radical retropubic prostatectomy by prior dissection of the seminal vesicles and vasa deferentia.

    abstract:OBJECTIVE:To develop a convenient technique for dividing the bladder neck during radical retropubic prostatectomy. METHOD:Before opening the bladder, we created a plane that separates the anterior surface of the seminal vesicles from the posterior wall of the bladder and ran an umbilical tape through the plane. The po...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000067980

    authors: Barré C,Pocholle P,Chauveau P

    更新日期:1999-08-01 00:00:00

  • Telesurgical laparoscopic radical prostatectomy. Initial experience.

    abstract:INTRODUCTION:Telepresence surgery offers theoretically to overcome two main problems of laparoscopic surgery, i.e. the limitation to only four degrees of freedom and the lack of stereovision. Since 1998, telesurgical minimally invasive procedures have been performed with the da Vinci system mainly for cardiac bypass su...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000049752

    authors: Rassweiler J,Frede T,Seemann O,Stock C,Sentker L

    更新日期:2001-07-01 00:00:00

  • Postpubertal cryptorchism. Morphofunctional study with special reference to Leydig's cells.

    abstract::In a group of 17 patients of postpubertal age with unilateral (n = 15) or bilateral (n = 2) cryptorchism, a significant decrease in the tubular diameter was observed, in addition to Leydig cell hyperplasia (many with cytoplasm vacuolization and/or atrophy) in both the cryptorchid testes and in the contralateral scrota...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000471635

    authors: Sirvent JJ,Bernat R,Rodriguez Tolra J,Navarro MA,Garcia B,Brunet J

    更新日期:1989-01-01 00:00:00

  • Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair.

    abstract:CONTEXT:Varicocele is a common condition, found in many men who present for infertility evaluation. OBJECTIVE:To assess the effect of varicocelectomy on male infertility. EVIDENCE ACQUISITION:A literature search was performed using Embase and Medline. Literature reviewed included meta-analyses and randomized and nonr...

    journal_title:European urology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.eururo.2011.06.018

    authors: Baazeem A,Belzile E,Ciampi A,Dohle G,Jarvi K,Salonia A,Weidner W,Zini A

    更新日期:2011-10-01 00:00:00

  • A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.

    abstract:BACKGROUND:Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic, disabling bladder disease, with an uncertain pathophysiology and no universally effective treatment. OBJECTIVE:To evaluate the efficacy and safety of certolizumab pegol compared with placebo in women with refractory IC/BPS. DESIGN, SETTING,...

    journal_title:European urology

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.eururo.2018.07.026

    authors: Bosch PC

    更新日期:2018-11-01 00:00:00